by Jordana Choucair | Jun 21, 2022 | Life Sciences
fizer agreed to invest $95 million to buy an 8.1 percent percent stake in French vaccines company Valneva. Pfizer and Valneva previously partnered to create a joint Lyme disease program, which is developing a Lyme disease vaccine candidate called VLA15. Valneva is...
by Jordana Choucair | Jun 17, 2022 | Life Sciences
The Federal Trade Commission (FTC) released a policy statement that it plans to “ramp up enforcement” on the prescription drug industry over illegal rebates and other fees that inhibit patients’ access to lower-cost medicines. The FTC, which...
by Jordana Choucair | Jun 17, 2022 | Life Sciences
Walgreens Boots Alliance Inc. is in active discussions with drug and biotech manufacturers as it moves forward with its plans to launch its first clinical trial before the end of 2022. Walgreens has partnered with the medical data company Pluto Health to access...
by Jordana Choucair | Jun 17, 2022 | Life Sciences
A newly unsealed whistleblower suit claims that multiple CVS Health subsidiaries coordinated to prevent members from accessing generic drugs. According to the lawsuit, CVS’ SilverScripts Part D subsidiary as well as its Caremark pharmacy benefit manager and...
by Jordana Choucair | Jun 16, 2022 | Life Sciences
A committee of advisers to the Food and Drug Administration (FDA) voted unanimously to recommend that the agency authorize COVID-19 vaccines from Moderna and Pfizer-BioNTech for children as young as 6 months. The agency is expected to authorize the vaccines soon. A...
by Jordana Choucair | Jun 16, 2022 | Life Sciences
Moderna Inc. is planning to test its COVID-19 vaccine in babies 3 months to 6 months old, the youngest age group studied to date. The biotech company said it is in the final stages of planning the “BabyCove” study and expects to begin enrolling as many as 700 babies...
Recent Comments